Jensen Claus Torp 4
4 · Teladoc Health, Inc. · Filed Dec 5, 2023
Insider Transaction Report
Form 4
Jensen Claus Torp
Chief Innovation Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-12-01−2,043→ 12,264 total→ Common Stock (2,043 underlying) - Exercise/Conversion
Common Stock
2023-12-01+2,043→ 20,703 total - Exercise/Conversion
Common Stock
2023-12-01+2,807→ 18,660 total - Exercise/Conversion
Restricted Stock Units
2023-12-01−2,807→ 14,038 total→ Common Stock (2,807 underlying)
Footnotes (3)
- [F1]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F2]On March 1, 2022, the reporting person was granted 33,688 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F3]On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.